AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data
Thrasyvoulos Tzellos presents in this MEDtalk the results from a multinational prospective long-term study that assessed both efficacy and safety for treatment with dupilumab in real-world practice. According to Thrasyvoulos Tzellos, the study’s results are very promising in terms of safety.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in